Look at me; I’m blogging! Welcome to http://www.carbwars.blogspot.com/. I have added this Web log to my Website, which will make it much easier to add content. I’m learning the ropes, so bear with me while I work out the kinks and grow some new brain cells to deal with all the techie stuff. Please stop by to visit often and share your comments and suggestions.
—Judy Barnes Baker
Can a Common Artificial Sweetener Fuel Anxiety?
www.medscape.com
An artificial sweetener commonly found in diet drinks and food is associated with an increased risk for anxiety-like behavior, early research suggests.
A recent metformin study casts doubts on longevity indications
peterattiamd.com
A new retrospective study contradicts previous evidence of metformin’s potential effects on lifespan extension in a general population, but for real answers, randomized trials are needed.
Brain structure and joint hypermobility: relevance to the expression of psychiatric symptoms
www.ncbi.nlm.nih.gov
Joint hypermobility is overrepresented among people with anxiety and can be associated with abnormal autonomic reactivity. We tested for associations between regional cerebral grey matter and hypermob...
More hype than substance: erythritol and cardiovascular risk
peterattiamd.com
A newly-published study caught public attention by reporting an association between the common sweetener erythritol and increased risk of heart attack and stroke, but there’s more to the story.
Whitney Webb Exposes Scary Truths About WHO's New Chief Scientist
youtube.com
In this video, investigative journalist Whitney Webb discusses the World Health Organization's (WHO) recent appointment of Jeremy Farrar as its new chief sci...
Princeton cancer researchers find that tumors’ metabolism is slower than suspected
www.princeton.edu
The discovery has vast implications for cancer treatment, showing that “starve the tumor” strategies are unlikely to be effective.
Lean mass loss on GLP-1 receptor agonists: a downside of the “miracle drugs”
peterattiamd.com
Clinical trials have generated impressive data on the effects of GLP-1 agonists on body weight and BMI, but how do these drugs perform in terms of body composition?
